{"id":13432,"date":"2016-06-01T17:13:07","date_gmt":"2016-06-01T21:13:07","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=13432"},"modified":"2016-06-01T17:13:07","modified_gmt":"2016-06-01T21:13:07","slug":"china-manufacturing-remains-under-duress-westpac","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/","title":{"rendered":"China manufacturing remains under duress | Westpac"},"content":{"rendered":"<p><img decoding=\"async\" title=\"Elliot Clarke\" alt=\"Elliot Clarke\" src=\"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358\" \/><\/p>\n<p>From Elliot Clarke:<\/p>\n<blockquote><p>There was little new information in the headline China manufacturing PMI results for May other than confirmation that the sector remains under duress. The official NBS measure was unchanged at 50.1, while the Caixin PMI edged 0.2ppts lower to 49.2. Also released today, the official non-manufacturing PMI deteriorated from 53.5 to 53.1.<\/p>\n<p>&#8230;..For manufacturing, both new order indexes deteriorated in May, to (a still expansionary 50.7) for the NBS survey and a (contractionary) 49.7 for the Caixin measure. This modest discrepancy corresponds to the greater external focus of the Caixin measure and the poor state of global demand. Export orders are falling according to Caixin respondents and are static amongst NBS\u2019 survey participants.<\/p>\n<p>Stocks of finished goods continue to contract, yet the absence of orders means that a pipeline of new work is struggling to build. On that basis, it seems unlikely that production will strengthen materially in the near term.<\/p>\n<p>Currently production is best described as stagnant&#8230;..<\/p>\n<p>Given the production and orders detail, it is unsurprising that employment continues to contract outright, at 48.2 and 46.3 respectively for the NBS and Caixin surveys.<\/p><\/blockquote>\n<p>Source: <a href=\"https:\/\/wibiq.westpac.com.au\/Publications.aspx?PublicationId=18528\" target=\"_blank\">Westpac: China PMI update May 2016<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From Elliot Clarke: There was little new information in the headline China manufacturing PMI results for May other than confirmation that the sector remains under duress. The official NBS measure was unchanged at 50.1, while the Caixin PMI edged 0.2ppts lower to 49.2. Also released today, the official non-manufacturing PMI deteriorated from 53.5 to 53.1. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;China manufacturing remains under duress | Westpac&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[41,5],"tags":[],"class_list":["post-13432","post","type-post","status-publish","format-standard","hentry","category-china-hk","category-economy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>China manufacturing remains under duress | Westpac - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China manufacturing remains under duress | Westpac - the patient investor\" \/>\n<meta property=\"og:description\" content=\"From Elliot Clarke: There was little new information in the headline China manufacturing PMI results for May other than confirmation that the sector remains under duress. The official NBS measure was unchanged at 50.1, while the Caixin PMI edged 0.2ppts lower to 49.2. Also released today, the official non-manufacturing PMI deteriorated from 53.5 to 53.1. &hellip; Continue reading &quot;China manufacturing remains under duress | Westpac&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-01T21:13:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"China manufacturing remains under duress | Westpac\",\"datePublished\":\"2016-06-01T21:13:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\"},\"wordCount\":191,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358\",\"articleSection\":[\"China &amp; HK\",\"Economy\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\",\"name\":\"China manufacturing remains under duress | Westpac - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358\",\"datePublished\":\"2016-06-01T21:13:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage\",\"url\":\"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358\",\"contentUrl\":\"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China manufacturing remains under duress | Westpac\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"China manufacturing remains under duress | Westpac - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"China manufacturing remains under duress | Westpac - the patient investor","og_description":"From Elliot Clarke: There was little new information in the headline China manufacturing PMI results for May other than confirmation that the sector remains under duress. The official NBS measure was unchanged at 50.1, while the Caixin PMI edged 0.2ppts lower to 49.2. Also released today, the official non-manufacturing PMI deteriorated from 53.5 to 53.1. &hellip; Continue reading \"China manufacturing remains under duress | Westpac\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2016-06-01T21:13:07+00:00","og_image":[{"url":"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"China manufacturing remains under duress | Westpac","datePublished":"2016-06-01T21:13:07+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/"},"wordCount":191,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage"},"thumbnailUrl":"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358","articleSection":["China &amp; HK","Economy"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/","name":"China manufacturing remains under duress | Westpac - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage"},"thumbnailUrl":"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358","datePublished":"2016-06-01T21:13:07+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#primaryimage","url":"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358","contentUrl":"https:\/\/wibiq.westpac.com.au\/ePortal\/CMSPages\/GetFile.aspx?nodeguid=aef9671c-f62d-46ec-a219-8529af18c358"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/06\/01\/china-manufacturing-remains-under-duress-westpac\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"China manufacturing remains under duress | Westpac"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3uE","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":63317,"url":"https:\/\/thepatientinvestor.com\/index.php\/2025\/11\/30\/chinas-nbs-manufacturing-pmi-for-november\/","url_meta":{"origin":13432,"position":0},"title":"China&#8217;s NBS Manufacturing PMI for November","author":"Colin Twiggs","date":"November 30, 2025","format":false,"excerpt":"China's NBS Manufacturing PMI increased to 49.2 for the month of November, up from 49.0 in October. The index indicates that the manufacturing sector has been contracting for the past 8 months, but only values below 49.0 are considered a risk-off signal. Conclusion The NBS Manufacturing PMI for China continues\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"China: NBS Manufacturing PMI","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-30-china-nbs-mnfg.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-30-china-nbs-mnfg.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-30-china-nbs-mnfg.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":55279,"url":"https:\/\/thepatientinvestor.com\/index.php\/2024\/07\/04\/asx-lifts-on-iron-ore-rally\/","url_meta":{"origin":13432,"position":1},"title":"ASX lifts on iron ore rally","author":"Colin Twiggs","date":"July 4, 2024","format":false,"excerpt":"The ASX 200 rallied on the back of a strong US overnight performance and an upsurge in iron ore prices. Rising Trend Index troughs signal buying pressure. The ASX 300 Metals & Mining climbed off the floor after an extended test of primary support at 5600. Boosted by an upsurge\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"ASX 200","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-07-03-xjo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-07-03-xjo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-07-03-xjo.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":63288,"url":"https:\/\/thepatientinvestor.com\/index.php\/2025\/11\/29\/asx-market-snapshot\/","url_meta":{"origin":13432,"position":2},"title":"ASX Market Snapshot","author":"Colin Twiggs","date":"November 29, 2025","format":false,"excerpt":"The gauge on the left indicates whether the market is in a bull or bear phase, while the one on the right reflects the current valuation of the stock market. Stock market pricing indicates whether stocks are cheap or expensive in relation to earnings, but it is a poor indicator\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"Bull-Bear Market Indicator","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-14-asx-bull-bear-gauge.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-14-asx-bull-bear-gauge.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-14-asx-bull-bear-gauge.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":12111,"url":"https:\/\/thepatientinvestor.com\/index.php\/2015\/07\/24\/chinese-manufacturing-activity-falls-in-july-the-new-york-times\/","url_meta":{"origin":13432,"position":3},"title":"Chinese Manufacturing Activity Falls in July &#8211; The New York Times","author":"ColinTwiggs","date":"July 24, 2015","format":false,"excerpt":"From Reuters: BEIJING \u2014 China's factory sector contracted by the most in 15 months in July as shrinking orders depressed output, a preliminary private survey showed on Friday, a worse-than-expected result that should reinforce bets the struggling Chinese economy will get more stimulus. The flash Caixin\/Markit China Manufacturing Purchasing Managers'\u2026","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":63343,"url":"https:\/\/thepatientinvestor.com\/index.php\/2025\/12\/06\/asx-market-snapshot-2\/","url_meta":{"origin":13432,"position":4},"title":"ASX Market Snapshot","author":"Colin Twiggs","date":"December 6, 2025","format":false,"excerpt":"The gauge on the left indicates whether the market is in a bull or bear phase, while the one on the right reflects the current valuation of the stock market. Stock market pricing indicates whether stocks are cheap or expensive in relation to earnings, but it is a poor indicator\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"Bull-Bear Market Indicator","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-14-asx-bull-bear-gauge.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-14-asx-bull-bear-gauge.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-11-14-asx-bull-bear-gauge.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":61681,"url":"https:\/\/thepatientinvestor.com\/index.php\/2025\/05\/17\/asx-weekly-leading-indicators\/","url_meta":{"origin":13432,"position":5},"title":"ASX Weekly Leading Indicators","author":"Colin Twiggs","date":"May 17, 2025","format":false,"excerpt":"The gauge on the left indicates bull or bear market status, while the right reflects stock market drawdown risk. Bull\/Bear Market The ASX Bull-Bear Market indicator is unchanged at 54%, signaling a mild bear market. Three of six indicators from Australia and China (our largest trading partner) signal risk-off. These\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"Bull-Bear Market Indicator","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-05-02-asx-bull-bear-gauge.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-05-02-asx-bull-bear-gauge.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2025\/2025-05-02-asx-bull-bear-gauge.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/13432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=13432"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/13432\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=13432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=13432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=13432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}